Filter by patients with: All

What is Rituximab?

Category: Prescription Drugs

Most popular types: Rituxan Mabthera

false

See also: DRC protocol FCMR protocol ILD Phase II/III Rituximab Versus Cyclophosphamide RECITAL Study R-CVP protocol RT protocol

Rituximab is a medication in a class of medications called monoclonal antibodies and given by infusion. It is used in the treatment of non-Hodgkins lymphoma and also in the treatment of rheumatoid arthritis.

See patients taking Rituximab

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Rheumatoid arthritis 886 49
Neuromyelitis optica 190 41
Chronic lymphocytic leukemia 165 11
Multiple sclerosis 155 90
Follicular lymphoma 62 10
Mantle cell lymphoma 40 3

Show all 107 reasons taken

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 2659 patients that have taken Rituximab

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 39
Moderate 44
Mild 89
None 89

Commonly reported side effects and conditions associated with Rituximab

Side effect Patients Percentage
Fatigue 36
Nausea 26
Headaches 11
Hair loss 7
Tiredness 6
Joint pain 5

Show all 120 reported side effects

Why patients stopped taking Rituximab

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 59
Did not seem to work 40
Doctor's advice 29
Side effects too severe 29
Other 21
Change in health plan coverage 5
Expense 4
Personal research 3
See all 164 patients who've stopped taking Rituximab

Duration

Stopped taking Rituximab

Duration Patients Percentage
Less than 1 month 66
1 - 6 months 31
6 months - 1 year 20
1 - 2 years 17
2 - 5 years 22
5 - 10 years 2
10 years or more 2
Adherence
Adherence Evaluations Percentage
Always 227
Usually 11
Sometimes 7
Never taken as prescribed 16
Burden
Burden Evaluations Percentage
Very hard to take 24
Somewhat hard to take 70
A little hard to take 80
Not at all hard to take 87
Cost per month
Cost per month Evaluations Percentage
$200+ 45
$100-199 12
$50-99 5
$25-49 4
< $25 74
Not specified 121

What people switch to and from

Patients started taking Rituximab after stopping:

Treatment Patients Percentage
Natalizumab (Tysabri) 21
Glatiramer acetate (Copaxone) 19
Dimethyl fumarate (Tecfidera) 12
Abatacept (Orencia) 10
Fingolimod (Gilenya) 10

Show all 32 treatments patients report switching from

Patients stopped taking Rituximab and switched to:

Treatment Patients Percentage
Ocrelizumab (Ocrevus) 8
Tocilizumab (Actemra) 6
Mycophenolate mofetil (CellCept) 5
Abatacept (Orencia) 4
Natalizumab (Tysabri) 4

Show all 29 treatments patients report switching to

Last updated:

17 patient evaluations for Rituximab

Sort by: Most recent

May 18, 2018 (Started Jan 15, 2016)

  • Effectiveness
    Slight (for follicular lymphoma)
  • Effectiveness
    Slight (for non-Hodgkin's lymphoma)
  • Side effects
    Mild (fatigue)
  • Adherence
    Never taken as prescribed
  • Burden
    Somewhat hard to take
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly

Jan 29, 2017 (Started Jan 15, 2016)

  • Effectiveness
    Moderate (for follicular lymphoma)
  • Effectiveness
    Moderate (for non-Hodgkin's lymphoma)
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Cost: < $25 monthly

Dec 15, 2016 (Started Jan 15, 2016)

  • Effectiveness
    Slight (for follicular lymphoma)
  • Effectiveness
    Slight (for non-Hodgkin's lymphoma)
  • Side effects
    Moderate (fatigue)
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 10 mg Weekly
Cost: < $25 monthly
  • 0 helpful marks

Feb 15, 2017 (Started Jul 15, 2016)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: As needed
  • 1 helpful mark

Sep 24, 2016 (Started Sep 11, 2014)

  • Effectiveness
    Slight (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: As needed
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly

Jul 1, 2014 (Started Sep 11, 2014)

  • Effectiveness
    Slight (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Cost: < $25 monthly
  • 0 helpful marks
Last updated:
Showing 3 of 17 patient evaluations for Rituximab